COVID-19 drug
- India
Dr Reddy’s announces commercial launch of COVID-19 drug 2-DG
New Delhi: Drug major Dr Reddy’s Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet. The company will supply…
- Hyderabad
DRDO’s 2-DG effective against all Covid variants, says study
Hyderabad: The 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development organisation (DRDO) for the coronavirus treatment, effectively inhibits the SARS-CoV-2 multiplication and works against all variants of Covid-19, says a research study.…
- Middle East
COVID-19: Bahrain, Kuwait approve emergency use of ‘Sotrovimab’
Bahrain and Kuwait on Wednesday granted the emergency use of ‘Sotrovimab’, a new drug developed by GlaxoSmithKline (GSK) to treat people infected with the COVID-19, official news agencies of both countries reported.…
- Hyderabad
BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drug
New Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution of Baricitinib for the treatment of COVID-19…
- India
New anti-COVID drug ‘should work against various strains’: DRDO Chairperson
New Delhi: The Defence Research and Development Organisation’s (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said on Monday. “The…
- Hyderabad
Hyderabad: 2 pharmacy owners black market Remdesivir, arrested
Hyderabad: In yet another crackdown on black marketing of the Remdesivir drug on Tuesday (April 20),the city police arrested four persons, including two owners of pharmacies at Yousufguda and Nampally, for selling…
